Characterization of T Cell-Mediated Responses in Nonhealing and Healing Leishmania major Infections in the Absence of Endogenous IL-4

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3434-3443

  Kropf, Pascale ^a   Etges, Robert ^a   Schopf, Lisa ^b   Chung, Charles ^b   Sypek, Joe ^b   Müller, Ingrid ^a,c  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b PFIZER INC   (United States)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CLASSIFICATION; COMPARATIVE STUDY; DISEASE PREDISPOSITION; FEMALE; GENETICS; HELPER CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; LEISHMANIA MAJOR; MALE; MOUSE; MOUSE MUTANT; SECRETION; SKIN LEISHMANIASIS; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; IMMUNOPHENOTYPING; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0031255049     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted protein. J. Immunol. 136:2348.
2. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
3. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
4. Billiau, A. 1996. Interferon-γ in autoimmunity. Cytokine Growth Factor Rev. 7:25.
5. + T cells. Eur. J. Immunol. 24:343.
6. + T cells. Annu. Rev. Immunol. 12:635.
7. Kopf, M., G. LeGros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Köhler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
8. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
9. Pearce, E. J., and S. L. Reiner. 1995. Induction of Th2 responses in infectious diseases. Curr. Opin. Immunol. 7:497.
10. + T cells. J. Immunol. 139:1303.
11. + T cells in leishmaniasis. Immunol. Today 10:40.
12. + T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:161.
13. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:162.
14. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
15. Belosevic, M., D. S. Finbloom, P. H. van der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266.
16. Müller, I., T. Pedrazzini, J. P. Farrell, and J. Louis. 1989. T-cell responses and immunity to experimental infection with Leishmania major. Annu. Rev. Immunol. 7:561.
17. + T cell clones recognizing antigen(s) associated with live parasites. Eur. J. Immunol. 19:865.
18. + effector cells default to the Th2 pathway in interferon γ deficient mice infected with Leishmania major. J. Exp. Med. 179:1367.
19. + T cell response. J. Exp. Med. 181:961.
20. Bogdan, C., A. Gessner, and M. Röllinghoff. 1993. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189: 356.
21. Kopf, M., F. Brombacher, G. Köhler, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127.
22. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody: evidence for a T-cell-dependent, interferon-γ-independent mechanism. J. Exp. Med. 171:115.
23. + T cells. Int. Immunol. 3:587.
24. Nabors, G. S., and J. P. Farrell. 1994. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infect. Immun. 62:5498.
25. Noben-Trauth, N., P. Kropf, and I. Müller 1996. Susceptibility to Leishmania major infection in interleukin-4 deficient mice. Science 271:987.
26. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
27. Titus, R. G., Rh. Ceredig, J. C. Cerottini, and J. A. Louis. 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J. Immunol. 135:2108.
28. + T cells that promote parasite growth distinct from those mediating resistance? Immunol. Lett. 19:251.
29. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
30. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
31. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
32. Noben-Trauth, N., G. Köhler, K. Bürki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5:487.
33. Louis, J. A., E. Moedder, R. Behin, and H. Engers. 1979. Recognition of protozoan parasite antigens by murine T lymphocytes. I. Induction of specific T lymphocyte dependent proliferative response to Leishmania tropica. Eur. J. Immunol. 9:841.
34. Neva, F. A., D. Wyler, and T. Nash. 1979. Cutaneous leishmaniasis: a case with persistent organisms after treatment in presence of normal immune response. Am. J. Trop. Med. Hyg. 28:467.
35. Panosian, C. B., J. P. Sypek, and D. J. Wyler. 1984. Cell contact mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic. J. Immunol. 133:3358.
36. Sacks, D. L., and R. P. Da Silva. 1987. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J. Immunol. 139:3099.
37. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5 using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
38. Watanabe, Y., and T. Sakata. 1988. Highly efficient action of autocrine mouse interferon-γ expressed via a retroviral vector. Eur. J. Immunol. 18:1627.
39. Prat, M., G. Gribaudo, P. M. Comoglio, G. Cavallo, and S. Landolfo. 1984. Monoclonal antibodies against murine γ interferon. Proc. Natl. Acad. Sci. USA 81:4515.
40. Spitalny, G. L., and E. A. Havell. 1984. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1560.
41. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
42. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu3/T4 molecule. J. Immunol. 131:2445.
43. Slade, S. S., and J. Langhorne. 1989. Production of interferon-γ during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 179:353.
44. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545.
45. Taswell, C. 1981. Limiting dilution assay for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
46. Germann, T., M. K. Gately, D. S. Schoenhaut, M. Lohoff, F. Mattner, S.-C. Jin, E. Schmitt, and E. Rüde. 1994. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23:1762.
47. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor β. Eur. J. Immunol. 24:793.
48. Güler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984.
49. Kaufmann, S. H. E. 1995. Immunity to intracellular microbial pathogens. Immunol. Today 16:338.
50. Seder, R. A., B. L. Kelsall, and D. Jankovic. 1996. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 157:2745.
51. Trinchieri, G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
52. + T cells during initiation of infection. J. Exp. Med. 179:447.
53. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011.
54. Scott, P. 1996. Th cell development and regulation in experimental cutaneous leishmaniasis. In Th1 and Th2 Cells in Health and Disease, Vol. 63: Chemical Immunology. S. Romagnani, ed. S. Karger, Basel, p. 98.
55. Scott, P., A. Eaton, W. C. Gause, X. diZhou, and B. Hondowicz. 1996. Early IL-4 production does not predict susceptibility to Leishmania major. Exp. Parasitol. 84:178.
56. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16:371.
57. + T cells activated in a T helper type 2-like response in vivo. Eur. J. Immunol. 25:1168.
58. Zubiaga, A. M., E. Munoz, and B. T. Huber. 1991. Production of IL-1α by activated Th type 2 cells: its role as an autocrine growth factor. J. Immunol. 146:3849.
59. Tartakovsky, B., A. Finnegan, K. Muegge, D. T. Brody, E. J. Kovacs, M. R. Smith, J. A. Berzofsky, H. A. Young, and S. K. Durum. 1988. IL-1 is an autocrine growth factor for T cell clones. J. Immunol. 141:3863.
60. Kalinski, P., C. M. U. Hilkens, E. A. Wierenga, T. C. T. M. van der Pouw-Kraan, R. A. van Lier, J. D. Bos, M. L. Kapsenberg, and F. G. M. Snijdewint. 1995. Functional maturation of human naive T helper cells in the absence of accessory cells. J. Immunol. 154:3753.
61. Huber, M., A. Rutherford, W. Meister, A. Weiss, M. Röllinghoff, and M. Lohoff. 1996. TcR-and IL-1-mediated co-stimulation reveals an IL-4-independent way of Th2 cell proliferation. Int. Immunol. 8:1257.
62. Müller, I., R. Titus, I. Caldumbide, and J. A. Louis. 1989. T cell responses in resistance and susceptibility to experimental leishmaniasis. In Frontiers of Infectious Diseases: New Strategies in Parasitology. K. McAdam, ed. Churchill Livingston, London, p. 158.
63. DaSilva, R. P., B. F. Hall, K. A. Joiner, and D. L. Sacks. 1989. CR1, the C3b receptor mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143:617.
64. Vieira, L. Q., B. D. Hondowicz, L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1994. Infection with Leishmania major induces interleukin-12 production in vivo. Immunol. Lett. 40:157.
65. Scott, P. 1996. Th cell development and regulation in experimental cutaneous leishmaniasis. In Th1 and Th2 Cells in Health and Disease. Vol. 63: Chemical Immunology. S. Romagnani, ed. S. Karger, Basel, p. 98.
66. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Müller, R. Kühn, and D. L. Sacks. 1995. Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515.
67. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
68. Gollob, J. A., H. Kawasaki, and J. Ritz. 1997. Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur. J. Immunol. 27:647.
69. Nabors, G. S., L. C. C. Afonso, J. P. Farrell, and P. Scott. 1995. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proc. Natl. Acad. Sci. USA 92:3142.
70. Leal, L. M. C. C., D. W. Moss, R. Kuhn, W. Müller, and F. Y. Liew. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23:566.